Lactase persistence as the clearest case study in gene-diet coevolution

Which state is the unusual one

Most mammals stop producing the enzyme that breaks down milk sugar shortly after weaning, because the sugar is not encountered again. Humans followed the same pattern for most of the species history, and continued production into adulthood is the newer and rarer arrangement. Framing the ancestral condition as an intolerance therefore inverts the biology, since persistence is the trait that requires explanation.

The proportion of adults who retain production varies enormously between populations, tracking the history of dairying rather than geography alone. This makes the trait one of the most striking examples of a dietary practice leaving a legible mark in human genomes.

Different populations, different variants

The genetic changes responsible do not sit inside the gene encoding the enzyme but in nearby regulatory sequence controlling whether it stays active. Several distinct variants achieving the same regulatory effect have been identified in populations with independent histories of dairying. That independent arrival at the same functional outcome is exactly what evolutionary biologists mean by convergence, and it is unusually clear here.

It also means a genetic test using a single variant will misclassify people from populations where a different variant is responsible. Consumer reports do not always state which variants they examined, which sharply limits how much weight a negative result from one of them deserves. The regulatory location of the variants also explains why enzyme production declines gradually across childhood rather than switching off at a single point.

How the enzyme deficiency produces symptoms

When the sugar is not broken down in the small intestine, it passes into the colon where resident bacteria ferment it. Fermentation produces gas and short-chain acids, and the unabsorbed sugar draws water into the intestinal lumen through osmosis. The resulting symptoms are therefore a consequence of microbial activity and osmotic effects rather than of any immune reaction.

This distinguishes the condition sharply from milk protein allergy, which involves an immune mechanism and different clinical management. The two are frequently confused in everyday conversation, and the distinction matters because the implications differ substantially.

Why genotype does not determine symptoms

The amount of sugar consumed at one time strongly influences whether symptoms occur, so small quantities are often tolerated without difficulty. Consuming the sugar alongside other food slows transit and spreads the load, which changes the response to an identical quantity. The colonic microbial community also adapts with repeated exposure, shifting toward organisms that ferment the sugar with less gas production.

Because of that adaptation, tolerance can change over weeks of regular consumption without any change in enzyme production at all. Fermented dairy products contain less of the sugar to begin with, which is a further reason genotype predicts symptoms imperfectly.

What the example teaches about nutrigenomics generally

This trait is cited constantly because it is the cleanest available case, involving a single gene with a large and well-understood effect. Almost no other diet-related trait has that structure, and most involve many genes each contributing a small and context-dependent effect. Generalising from this example to personalised nutrition therefore extrapolates from the most favourable case available to the field.

The honest lesson is that gene-diet interaction is real and that its clearest instance is unusually simple rather than typical. Anyone with persistent digestive symptoms should be assessed clinically, since several conditions produce a similar picture and are managed differently.